DENTSPLY SIRONA
Market Cap
US$11.2b
Last Updated
2019/09/18 23:34 UTC
Data Sources
Company Financials +
Executive Summary
DENTSPLY SIRONA Inc. designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide.
Snowflake
Fundamentals
Excellent balance sheet with moderate growth potential.
Similar Companies
Share Price & News
How has DENTSPLY SIRONA's share price performed over time and what events caused price changes?
Latest Share Price and Events
Market Performance
7 Day Return
-2.5%
NasdaqGS:XRAY
0.5%
US Medical Equipment
-0.02%
US Market
1 Year Return
29.1%
NasdaqGS:XRAY
9.9%
US Medical Equipment
1.6%
US Market
XRAY outperformed the Medical Equipment industry which returned 9.7% over the past year.
XRAY outperformed the Market in United States of America which returned 1.9% over the past year.
Share holder returns
| XRAY | Industry | Market | |
|---|---|---|---|
| 7 Day | -2.5% | 0.5% | -0.02% |
| 30 Day | -6.9% | 0.09% | 2.7% |
| 90 Day | -13.2% | 2.0% | 1.4% |
| 1 Year | 30.2%29.1% | 10.8%9.9% | 3.8%1.6% |
| 3 Year | -15.1%-16.7% | 69.0%63.9% | 45.2%35.8% |
| 5 Year | 11.0%7.9% | 136.2%109.3% | 61.8%44.1% |
Price Volatility Vs. Market
How volatile is DENTSPLY SIRONA's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 months ago | Simply Wall St
Who Has Been Selling DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares?2 months ago | Simply Wall St
Did DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Insiders Sell Shares?3 months ago | Simply Wall St
Why DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Is A Financially Healthy CompanyValuation
Is DENTSPLY SIRONA undervalued based on future cash flows and its price relative to the stock market?
105.52x
Price to Earnings (PE) ratio
Intrinsic Value Based on Future Cash Flows
DENTSPLY SIRONA's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).
DENTSPLY SIRONA's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).
Price Based on Earnings
DENTSPLY SIRONA is overvalued based on earnings compared to the US Medical Equipment industry average.
DENTSPLY SIRONA is overvalued based on earnings compared to the United States of America market.
Price Based on Expected Growth
DENTSPLY SIRONA is poor value based on expected growth next year.
Price Based on Value of Assets
DENTSPLY SIRONA is good value based on assets compared to the US Medical Equipment industry average.
Next Steps
Future Growth
How is DENTSPLY SIRONA expected to perform in the next 1 to 3 years based on estimates from 17 analysts?
33.6%
Forecasted annual earnings growth
Earnings and Revenue Growth Estimates
Future Annual Growth Analysis
DENTSPLY SIRONA's revenue is expected to grow by 3.3% yearly, however this is not considered high growth (20% yearly).
DENTSPLY SIRONA's earnings are expected to grow significantly at over 20% yearly.
DENTSPLY SIRONA's revenue growth is positive but not above the United States of America market average.
DENTSPLY SIRONA's earnings growth is expected to exceed the United States of America market average.
DENTSPLY SIRONA's earnings growth is expected to exceed the low risk savings rate of 2.7%.
Earnings per Share Growth Estimates
Future Return on Equity
DENTSPLY SIRONA is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
Next Steps
Past Performance
How has DENTSPLY SIRONA performed over the past 5 years?
-56.0%
Historical annual earnings growth
Earnings and Revenue History
Past Earnings Growth Analysis
DENTSPLY SIRONA's year on year earnings growth rate was negative over the past 5 years, however the most recent earnings are above average.
DENTSPLY SIRONA has become profitable in the last year making the earnings growth rate difficult to compare to the 5-year average.
DENTSPLY SIRONA has become profitable in the last year making it difficult to compare the US Medical Equipment industry average.
Return on Equity
DENTSPLY SIRONA has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
Return on Assets
DENTSPLY SIRONA used its assets less efficiently than the US Medical Equipment industry average last year based on Return on Assets.
Return on Capital Employed
DENTSPLY SIRONA has improved its use of capital last year versus 3 years ago (Return on Capital Employed).
Next Steps
Financial Health
How is DENTSPLY SIRONA's financial position?
Financial Position Analysis
DENTSPLY SIRONA is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
DENTSPLY SIRONA's long term commitments exceed its cash and other short term assets.
Debt to Equity History and Analysis
DENTSPLY SIRONA's level of debt (28.9%) compared to net worth is satisfactory (less than 40%).
The level of debt compared to net worth has been reduced over the past 5 years (55.3% vs 28.9% today).
Debt is well covered by operating cash flow (33.6%, greater than 20% of total debt).
Interest payments on debt are well covered by earnings (EBIT is 9.9x coverage).
Balance Sheet
Low level of unsold assets.
Debt is covered by short term assets, assets are 1.2x debt.
Next Steps
Dividend
What is DENTSPLY SIRONA's current dividend yield, its reliability and sustainability?
0.75%
Expected Dividend Yield
Upcoming Dividend Payment
Purchase DENTSPLY SIRONA before the 'Buy Limit' to receive their next dividend payment.
Dividend Yield and Payments Analysis
DENTSPLY SIRONA's pays a lower dividend yield than the bottom 25% of dividend payers in United States of America (1.44%).
DENTSPLY SIRONA's dividend is below the markets top 25% of dividend payers in United States of America (3.69%).
DENTSPLY SIRONA is not paying a notable dividend for United States of America, therefore no need to check if the payments are stable.
DENTSPLY SIRONA is not paying a notable dividend for United States of America, therefore no need to check if the payments are increasing.
Current Payout to Shareholders
No need to calculate the sustainability of DENTSPLY SIRONA's dividends as it is not paying a notable one for United States of America.
Future Payout to Shareholders
No need to calculate the sustainability of DENTSPLY SIRONA's dividends in 3 years as they are not expected to pay a notable one for United States of America.
Next Steps
Management
What is the CEO of DENTSPLY SIRONA's salary, the management and board of directors tenure and is there insider trading?
2.0yrs
Average management tenure
CEO
Don Casey (59yo)
1.6yrs
Tenure
US$11,338,542
Compensation
Mr. Donald M. Casey, Jr., also known as Don, serves as CEO and Director at DENTSPLY International Inc., since 2018. Mr. Casey has been Chief Executive Officer and a Director at Dentsply Sirona Inc. since ...
CEO Compensation Analysis
Don's remuneration is about average for companies of similar size in United States of America.
Insufficient data for Don to compare compensation growth.
Management Age and Tenure
2.0yrs
Average Tenure
55yo
Average Age
The tenure for the DENTSPLY SIRONA management team is about average.
Board Age and Tenure
2.8yrs
Average Tenure
63.5yo
Average Age
The average tenure for the DENTSPLY SIRONA board of directors is less than 3 years, this suggests a new board.
Insider Trading
No 3 month open market individual insider trading information.
Recent Insider Transactions
| Entity | Individual |
| Role | Member of the Board of Directors Independent Director |
| Shares | 2,720 |
| Max Price | US$55.31 |
| Entity | Individual |
| Role | Chief Executive Officer CEO & Director |
| Shares | 10,000 |
| Max Price | US$53.68 |
| Entity | Individual |
| Role | Member of the Board of Directors Independent Director |
| Shares | 1,898 |
| Max Price | US$53.77 |
| Entity | Individual |
| Role | Member of the Board of Directors Independent Director |
| Shares | 10,000 |
| Max Price | US$53.60 |
| Entity | Individual |
| Role | Head of Human Resources Senior VP |
| Shares | 22,302 |
| Max Price | US$55.00 |
| Entity | Individual |
| Role | Senior Key Executive Senior Vice President of Chairside Consumables |
| Shares | 3,000 |
| Max Price | US$54.73 |
| Entity | Individual |
| Shares | 3,697 |
| Max Price | US$54.68 |
| Entity | Individual |
| Role | Member of the Board of Directors Independent Director |
| Shares | 2,632 |
| Max Price | US$66.52 |
| Entity | Individual |
| Role | Senior Key Executive Senior Vice President of EMEA RCO |
| Shares | 3,273 |
| Max Price | US$37.87 |
Ownership Breakdown
Management Team
Don Casey (59yo)
CEO & Director
- Tenure: 1.6yrs
- Compensation: US$11.34m
John Sweeney
Vice President of Investor Relations
- Tenure: 0yrs
Jorge Gomez (51yo)
Executive VP & CFO
- Tenure: 0.08yrs
Keith Ebling (50yo)
EVP, General Counsel & Secretary
- Tenure: 1.9yrs
- Compensation: US$2.33m
Albert Sterkenburg (55yo)
Senior Vice President
- Tenure: 10.7yrs
- Compensation: US$1.35m
Maureen MacInnis (58yo)
Senior VP
- Tenure: 10.4yrs
- Compensation: US$1.09m
Markus Boehringer (55yo)
Senior Vice President of EMEA RCO
- Tenure: 2.2yrs
- Compensation: US$1.52m
Teresa Dolan
Chief Clinical Officer & VP
- Tenure: 0yrs
Bill Newell (57yo)
Senior Vice President of Chairside Consumables
- Tenure: 2.2yrs
- Compensation: US$1.48m
Cord Staehler
Chief Technology Officer
- Tenure: 0.3yrs
Board Members
Francis Lunger (73yo)
Independent Director
- Tenure: 14.3yrs
- Compensation: US$282.50k
Eric Brandt (57yo)
Non-Executive Chairman
- Tenure: 2yrs
- Compensation: US$398.88k
Harry M. Kraemer (64yo)
Independent Director
- Tenure: 3.6yrs
- Compensation: US$270.00k
Betsy Holden (63yo)
Independent Director
- Tenure: 1.7yrs
- Compensation: US$261.75k
Michael Alfano (71yo)
Independent Director
- Tenure: 18.6yrs
- Compensation: US$270.00k
Leslie Varon (62yo)
Independent Director
- Tenure: 1.7yrs
- Compensation: US$264.16k
Greg Lucier (55yo)
Independent Director
- Tenure: 0.3yrs
Arthur Kowaloff (72yo)
Independent Director
- Tenure: 3.6yrs
- Compensation: US$272.50k
Don Casey (59yo)
CEO & Director
- Tenure: 1.6yrs
- Compensation: US$11.34m
Willie Deese (64yo)
Independent Director
- Tenure: 8.6yrs
- Compensation: US$272.50k
Company Information
DENTSPLY SIRONA Inc.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: DENTSPLY SIRONA Inc.
- Ticker: XRAY
- Exchange: NasdaqGS
- Founded: 1899
- Industry: Health Care Supplies
- Sector: Healthcare
- Market Cap: US$11.178b
- Shares outstanding: 224.18m
- Website: https://www.dentsplysirona.com
Number of Employees
Location
- DENTSPLY SIRONA Inc.
- 13320 Ballantyne Corporate Place
- Charlotte
- North Carolina
- 28277
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| XRAY | NasdaqGS (Nasdaq Global Select) | Yes | Common Stock | US | USD | Aug 1987 |
| DY2 | DB (Deutsche Boerse AG) | Yes | Common Stock | DE | EUR | Aug 1987 |
| 0I8F | LSE (London Stock Exchange) | Yes | Common Stock | GB | USD | Aug 1987 |
| XRAY | WBAG (Wiener Boerse AG) | Yes | Common Stock | AT | EUR | Aug 1987 |
| XRAY34 | BOVESPA (Bolsa de Valores de Sao Paulo) | BDR EACH REP 1 COM USD0.01 | BR | BRL | May 2019 |
Biography
DENTSPLY SIRONA Inc. designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. T ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2019/09/18 23:34 |
| End of Day Share Price | 2019/09/18 00:00 |
| Earnings | 2019/06/30 |
| Annual Earnings | 2018/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.